EC330 is a steroidal inhibitor of leukemia inhibitory factor (LIF, an interleukin 6 class cytokine). EC330 inhibits the LIF/LIF-R signaling and blocks the promoting effects of LIF on growth and migration of cancer cells.
EC330, a potential LIF inhibitor, inhibits the activation of STAT3, PI3K/AKT, and mTOR signaling pathways by LIF, preferentially inhibits the proliferation of cancer cells with LIF overexpression, also inhibits LIF function in promoting migration of cancer cells.[1]
EC330 inhibits multi-functional cytokine LIF function in promoting tumor growth in vivo.[1]
[1] Xuetian Yue, et al. J Mol Cell Biol. 2020 Jul 3;12(6):477-480.
















